geny3

12.

12.

13.

14.

15.

16. 17.

18.

19.

20. 21. 22.

23.

24.

25.

26.

27.

28.

Parker JF, et al.: Pancreatic carcinoma surveillance in patients with familial melanoma. Arch Dermatol 2003,139:1019-25.    -fp

Borg A, et al.: High freąuency of multiple melanomas and breast and pancreas carcinomas itt CDKN2A& mutation-positive melanoma families. J Natl Cancer Inst 2000, 92: 1260-6.    ' ji»

Kaufman DK, et al.: A familial syndrome with cutaneous malignant melanoma and cerebral asłrocytortia;^ Neurology 1993, 43: 1728-31.

Tsao H: Updatc on familial cancer syndromes and the skin. J Am Acad Dermatol 2000,42: 939-71, Hussussian CJ, et al.: Germiine pl 6 mutations in familial melanoma. Nat Genet 1994,8: 15-21.

Kamb A, et al.: Analysis of the p 16 gene (CDKN2) as a candidate for the chromosome 9p melanoma siS* ceptibility locus. Nat Genet 1994, 8: 22-6.    :

Bishop DT, et al.: Melanoma Genetics Consortium. Geographical variation in the penetrance of CDKNi mutations for melanoma. J Natl Cancer Inst 2002, 94: 894-903.

Soufir N, et al.: Preva!ence of pi 6 and CDK.4 germiine mutations in 48 melanoma-prone families itjj France. The French Familial Melanoma Study Group. Hum Mol Genet 1998, 7: 941.    .

FitzGerald MG, et al.: Prevalence of germ-line mutations in p 16, p!9ARF, and CDK4 in familia! melas? noma: analysis of a clinic-based population. Proc Natl Acad Sci USA 1996, 93: 8541-5.

Platz A, Hansson J, Ringborg U: Screening of germiine mutations in the CDK.4, CDKN2C and TPjp" genes in familial melanoma: a clinic-based population study. Int J Cancer 1998,25: 13-5.

Platz A, et al.: Screening of germiine mutations in the CDKN2A and CDKN2B genes in Swedish familie' with hereditary cutaneous melanoma. J Natl Cancer Inst 1997, 89: 697-702.

Dębniak T, et a!.: Germiine mutation and large deletion analysis of the CDKN2A and ARF genes in BnP* lies with multiple melanoma or an aggregation of malignant melanoma and breast cancer. Int J Caticeh 2004,110:558-62.

Bressac-de-Pailierets B, et al.: Genetic and environmental factors in cutaneous malignant melanoma.'Bióf chimie 2002, 84: 67-74.    ^!f?f§

Dębniak T, et al.: The CDKN2A coinmon variants and their association with melanoma risk: a populatló*⁵ based study. Cancer Res 2005, 65: 835-9.    ^j„

Tomescu D, et al.: Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to. pnie " lanoma. Carcinogenesis 2001, 22: 403-8.

Dębniak T, et al. MC1R comraoa variants, CDKN2A and their association with melanoma and breast jją’ cer risk. Int J Cancer 2006, 119: 2597-602.

Scott RJ, et al.: BR<£A2 mutations in a population-based series of patients with ocular Int J Cancer 2002, 102: 188-91.    . ,